U.S. Markets open in 3 hrs 20 mins

EyeGate Pharmaceuticals, Inc. (EYEG)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.1200-0.1800 (-5.45%)
At close: 4:00PM EDT
6.5000 +3.38 (108.33%)
Pre-Market: 06:09AM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.16
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 38.1800
52 Week Low 33.1063
50-Day Moving Average 33.9679
200-Day Moving Average 34.9784

Share Statistics

Avg Vol (3 month) 328.02k
Avg Vol (10 day) 345.62k
Shares Outstanding 57.1M
Implied Shares Outstanding 6N/A
Float 5.03M
% Held by Insiders 13.77%
% Held by Institutions 155.81%
Shares Short (May 27, 2021) 43.55k
Short Ratio (May 27, 2021) 40.16
Short % of Float (May 27, 2021) 40.10%
Short % of Shares Outstanding (May 27, 2021) 40.05%
Shares Short (prior month Apr 29, 2021) 43.88k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Aug 29, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Aug 29, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-69,727.97%

Management Effectiveness

Return on Assets (ttm)-32.04%
Return on Equity (ttm)-79.27%

Income Statement

Revenue (ttm)12.06k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-3.55M
Net Income Avi to Common (ttm)-8.72M
Diluted EPS (ttm)-1.7680
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.61M
Total Cash Per Share (mrq)0.93
Total Debt (mrq)520.92k
Total Debt/Equity (mrq)4.11
Current Ratio (mrq)4.90
Book Value Per Share (mrq)1.26

Cash Flow Statement

Operating Cash Flow (ttm)-7.49M
Levered Free Cash Flow (ttm)-3.51M